← Leaderboards
Ying Maggie Chen
Washington University
$5,605,322
Attributed
$5,723,197
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,723,197 · 5
VA$0 · 1
By mechanism
R01$4,494,015 · 1
K08$640,932 · 1
R21$235,750 · 1
R56$200,000 · 1
R03$152,500 · 1
I01$0 · 1
Top collaborators
- Srikanth Singamaneni1 shared
Most similar at Washington University
Same institution · by research overlap
- Jeffrey H Miner$20,654,870
- Phyllis I Hanson$10,362,319
- Srikanth Singamaneni$1,783,222
- Sumanth Gandra$202,356
- Srikanth Singamaneni$2,566,537
Others in their field
Top investigators on “Kidney Diseases”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,643,195
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Rose A Gubitosi-Klug · Case Western Reserve University$66,444,881
Research focus
Kidney DiseasesMouse ModelProteinsMutationKidney FailureEndoplasmic Reticulum StressMutantIn VivoKidneyLeadTransgenic MiceMolecularEndoplasmic ReticulumProteinuriaPathogenesisVariantNephrotic SyndromeMissense MutationLamininAttenuatedLamin B2CellsPodocyteGlomerular Basement Membrane
Grant awards (17)
Activating Autophagy to Treat Uromodulin-Associated Genetic Chronic Kidney Disease$2,969,015
R01 · FY2025 · DK · contact PI
Therapeutic Targeting of Mitochondria in Uromodulin-Associated Chronic Kidney Disease$0
I01 · FY2025 · VA · contact PI
Develop Autophagy Activators to Treat Autosomal Dominant Tubulointerstitial Kidney Disease$200,000
R56 · FY2024 · DK · contact PI
Therapeutic Targeting of Mitochondria in Uromodulin-Associated Chronic Kidney Disease$0
I01 · FY2024 · VA · contact PI
Ultrabright Plasmonic-Fluor Nanosensor-Enabled Noninvasive Management of Pediatric Nephrotic Syndrome$235,750
R21 · FY2022 · DK · contact PI
PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME$305,000
R01 · FY2021 · DK · contact PI
PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME$305,000
R01 · FY2020 · DK · contact PI
PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME$305,000
R01 · FY2019 · DK · contact PI
PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME$305,000
R01 · FY2018 · DK · contact PI
PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME$305,000
R01 · FY2017 · DK · contact PI
PHARMACOLOGICAL RESCUE OF MUTANT LAMININ IN NEPHROTIC SYNDROME$76,250
R03 · FY2016 · DK · contact PI
PHARMACOLOGICAL RESCUE OF MUTANT LAMININ IN NEPHROTIC SYNDROME$76,250
R03 · FY2015 · DK · contact PI
Mutant Laminin Chains and Nephrotic Syndrome$128,347
K08 · FY2014 · DK · contact PI
Mutant Laminin Chains and Nephrotic Syndrome$128,481
K08 · FY2013 · DK · contact PI
Mutant Laminin Chains and Nephrotic Syndrome$128,613
K08 · FY2012 · DK · contact PI
Mutant Laminin Chains and Nephrotic Syndrome$128,742
K08 · FY2011 · DK · contact PI
Mutant Laminin Chains and Nephrotic Syndrome$126,749
K08 · FY2010 · DK · contact PI